共 388 条
[1]
Smith DA(1985)Chromone-2-carboxylic acids: roles of acidity and lipophilicity in drug disposition Drug Metab Rev 16 365-388
[2]
Brown K(2009)Albumin as fatty acid transporter Drug Metab. Pharmacokinet 24 300-307
[3]
Neale MG(2013)Fatty acids as therapeutic auxiliaries for oral and parenteral formulations Adv Drug Deliv Rev 65 1331-1339
[4]
van der Vusse GJ(1974)BRL.8988 (talampicillin), a well-absorbed oral form of ampicillin Antimicrob Agents Chemother 5 670-671
[5]
Hackett MJ(1997)Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume J. Pharmacol. Exp. Ther 281 93-102
[6]
Zaro JL(1996)Improved passive oral delivery via prodrugs Adv Drug Deliv Rev 19 131-148
[7]
Shen WC(2011)Intestinal lymphatic transport for drug delivery Adv Drug Deliv Rev 63 923-942
[8]
Guley PC(1996)Targeting of drug to the hepatocytes by fatty acids. Influence of the carrier (albumin or galactosylated albumin) on the fate of the fatty acids and their analogs Pharm Res 13 27-31
[9]
Cho MJ(2010)Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions J. Control. Release : Off J. Control. Release Society 142 214-220
[10]
Clayton JP(2000)Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats J Pharm Sci 89 1073-1084